01 · Process stage
PlannedMaterial characterisation
Determine the physical, chemical and structural properties of the target active substance.
Capabilities · Product & process development
Preformulation & formulation development
A proposed service scope for early-stage product evaluation, connecting active substance characterisation, excipient compatibility screening and final candidate selection for subsequent technical advancement.
PlannedCatalogue scope
Service statusPlanned
Planned.
Technical boundaries and readiness need confirmation before an activity could be presented as available.
Basis · Catalogue scope
- Status
- PlannedNo available service asserted
- Source-plan relationship
- Catalogue scopeProposed catalogue expansion
- Readiness
- Not establishedProduct and process evidence needed
- Facility roadmap
- First commercial batch target Q1 2028 · indicativeNot a service date
01 · Proposed service scope
Start with the product and its container.
Preformulation and formulation development is presented as a planned service domain. The exact product, target presentation and intended technical route would define its specific analytical and physical testing scope.
The initial Boten project plan identifies specific sterile preparation domains and protein raw-material production. This proposed formulation service lies outside the initial plan and would require explicit scope confirmation.
Active ingredient characterisation and final dosage-form design are distinct technical stages. Progression from material screening to a stable formulated composition would depend on the specific molecular properties involved.
Catalogue boundary
A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.
02 · Presentation families
Match the route to the format.
| Format | Planning note | Basis | Status |
|---|---|---|---|
| Biologic moleculesBiological drug-substance development | Characterisation requirements for complex proteins or related biological substances. | Catalogue scope | Planned |
| Small moleculesSmall-molecule active ingredients | Physicochemical evaluation and solubility profiling for typical chemical compounds. | Catalogue scope | Planned |
| Lyophilised presentationsLyophilisation cycle development | Thermal analysis and protectant screening for freeze-dried target profiles. | Catalogue scope | Planned |
| Liquid injectables | Acid-base optimisation, buffering and stability evaluation for aqueous formulations. | Catalogue scope | Planned |
03 · Process scope for discussion
Make the sequence and its evidence visible.
02 · Process stage
PlannedExcipient compatibility screening
Assess interactions between the active ingredient and proposed formulation components under stress.
03 · Process stage
PlannedSolubility & stability profiling
Evaluate target concentration limits and potential degradation pathways across different environmental conditions.
04 · Process stage
PlannedPrototype preparation
Produce initial experimental batches to evaluate physical behaviour and intended administration viability.
05 · Process stage
PlannedAnalytical method alignment
Establish the testing techniques required to monitor physical and chemical stability indicators.
06 · Process stage
PlannedCandidate selection review
Assess collected developmental data to nominate a specific composition for process scale-up.
Illustrative sequence
This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.
04 · Supporting services
No service stands alone.
01PlannedCatalogue scope
Process development & scale-up
Process definition, scale considerations and the evidence needed for transfer.
Explore proposed scope02PlannedCatalogue scope
Analytical method development
Product-specific test methods and analytical development questions.
Explore proposed scope03PlannedCatalogue scope
Small-molecule active ingredients
Proposed synthesis, isolation and purification domains; scope confirmation required.
Explore proposed scope05 · Readiness questions
A service claim needs a defined evidence base.
- Active substance data
- Comprehensive material safety information and any preliminary structural characteristics.
- Target product profile
- Intended administration route, dose strength and final presentation format.
- Analytical testing methods
- Available techniques for detecting the active substance and related degradation products.
- Facility & systems
- Appropriate installed laboratory equipment and a qualified testing environment.
- Quality responsibilities
- Defined rules for data recording, protocol approval and documentation practices.
- Technical agreement
- Agreed boundaries for intellectual property handling and experimental data exchange.
06 · Practical questions
Before a technical discussion.
Is this service currently available?
No. The service is Planned. This page is a scope proposal and does not establish an operating preformulation or formulation development service.
Does this domain cover all molecule types?
No. The exact chemical or biological nature of the active substance would determine the necessary analytical techniques, requiring separate technical feasibility assessment for each project.
What information helps define the question?
Identify the active substance class, target presentation, known material liabilities and specific formulation goals. Confidential molecular structure data should only be shared through an agreed route.
Is there a service launch quarter?
No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual development service to a start date.
Does a technical discussion establish supply?
No. Feasibility, scope, laboratory permissions, material evidence and a binding technical agreement would need to be established before any development service commitment.
Professional enquiries
Discuss a defined question.
Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.